Help improve lung cancer care by sharing your experience.

The PROPEL study is gathering real-world insights from people with a lung cancer diagnosis and those who care for them. By sharing your experiences, you can help improve access to life-saving precision medicine and shape the future of lung cancer care. Your voice will help researchers and policymakers understand the real-world impact of treatments, identify gaps in care, and push for meaningful change. Click to learn more about PROPEL. >>

Canada’s leading cancer killer is ready for a breakthrough.

Lung cancer continues to kill more patients each year than breast cancer, colon cancer, and prostate cancer combined.

72 people are diagnosed daily with lung cancer – of those individuals, 56 will lose their lives to the disease. Our mission is to foster lung cancer research in pursuit of new discoveries through the development of a comprehensive lung cancer repository.

PROPEL Study Announcement

We’re proud to announce that our research team led by Dr. Vishal Navani will receive $250,000 over the next year from the Marathon of Hope Cancer Centres Network, after being named one of the recipients of the Network’s Patient Voices in Research Initiative.

Funding from this award will support the launch of our new study called Patient Reported Outcomes in People Experiencing Lung Cancer (PROPEL). This study aims to provide evidence on how to improve lung cancer care by better understanding how patients and caregivers navigate their cancer journeys and what access they have to precision oncology treatments. Click to learn more about the award. >>

Today’s Information, Tomorrow’s Technology

Chances are that someone you know or love will be diagnosed with lung cancer. Help us improve the lives of future Albertans diagnosed with lung cancer.

Focused Funding, Focused Results

Financial contributions from our donors have made a significant difference to our work in lung cancer research here in Calgary and the province of Alberta. Future funding will increase the power of our research platform significantly and will lead to a very specialized and successful lung cancer research team.

Please Join Our Mission

Our work will support the development of future treatments and therapies for those diagnosed with lung cancer.

glr@ahs.ca

The Real Shame of Lung Cancer:
Canada’s leading cancer killer is also one of the least funded.

Lung cancer patients are often stigmatized and feel shame brought on by an uneducated and non-empathetic audience. While it is assumed all lung cancer victims have been smokers, a startling 20% have not. The ‘never-smoked’ patient is a growing percentage.

Regardless of their smoking status, 100% of lung cancer patients are entitled to a second breath at life. The only shame in lung cancer is how this stigma has directly led to how underfunded lung cancer research is. This is particularly obvious when compared to other cancer research programs. Lung cancer kills nearly all patients it affects and the research of this cancer is vital in order to treat it more effectively.

The Glans-Look Lung Cancer Research program was established in 2006, and has since enabled researchers to study patients with lung cancer with the goal of improving the quality of the care they receive.

uofc_250x95
ahs_250x95

Please Join Our Mission

Our work will support the development of future treatments and therapies for those diagnosed with lung cancer.